Implantica Presents The Third Quarter 2024 On November 15 At 15:00 CEST
Implantica Presents The Third Quarter 2024 On November 15 At 15:00 CEST . (MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 VADUZ, Liechtenstein, Nov. 8, 2024 /PRNewswire/ --  Implantica AG (publ) invites investors to a presentation of the third quarter 2024 at 15:00 CET on ...
América - MenaFN
VADUZ, Liechtenstein, Nov. 8, 2024 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the third quarter 2024 at 15:00 CET on November 15. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.

The presentation will be in English via an audiocast with teleconference:

If you wish to participate via webcast, please use the following link:

If you wish to participate via teleconference, please register on the below. After registration, you will be provided the phone number and a conference ID to access the conference.

Speakers:



CEO Peter Forsell

CFO Andreas Öhrnberg Chief Corporate Affairs Officer Nicole Pehrsson

For further information, please contact:

Nicole Pehrsson, Investor Relations

Telephone (CH): +41 (0)79 335 09 49

[email protected]

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company's Certified Adviser is FNCA Sweden AB, [email protected]

The information was sent for publication, through the agency of the contact person set out above, on November 8, 2024 at 11:50 a.m. CET.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStopTM, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit for further information.

This information was brought to you by Cision

,c4063573

The following files are available for download:
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108865238/Implantica-Presents-The-Third-Quarter-2024-On-November-15-At-1500-CEST
2024-11-08
rss
(MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 VADUZ, Liechtenstein, Nov. 8, 2024 /PRNewswire/ --  Implantica AG (publ) invites investors to a presentation of the third quarter 2024 at 15:00 CET on ...
Implantica Presents The Third Quarter 2024 On November 15 At 15:00 CEST